Researchers at the University of Miami Miller School of Medicine and The Miami Project to Cure Paralysis, along with their partners at Scythian Biosciences, are one step closer to finding a new treatment for concussion. In 2016, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD with an NMDA antagonist for the treatment of traumatic brain injury and concussion.
Sanjiv Bhatia, M.D., associate professor of clinical neurological surgery, passed away early Thursday morning, May 24. Bhatia was a prominent pediatric neurosurgeon who joined the faculty of the University of Miami Miller School of Medicine in 2004 and has since practiced at both Jackson Memorial Hospital’s Holtz Children’s Hospital and at Nicklaus Children’s Hospital.
For nearly 30 years, Mary Bartlett Bunge, Ph.D., worked tirelessly as a neuroscientist with The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine. Her pioneering work in the area of nervous system regeneration and her decades-long dedication to finding ways to repair spinal cord damage earned Bunge the 2018 Lifetime Achievement Award from the Greater Miami Chamber of Commerce.
The University of Miami Miller School of Medicine’s Department of Otolaryngology–Head and Neck Surgery is one of eight otolaryngology training programs in the U.S. to receive the Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32) for interdisciplinary research training in otolaryngology.
A new biotechnology startup with its origins in the work of two neuroscientists is capturing attention for its potential to revolutionize drug discovery at the University of Miami Miller School of Medicine. Truvitech’s patent-pending technology uses a unique combination of biochemical profiling, cell-based screening, and machine learning to rapidly discover responsive pharmacological targets.